.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Chubb
UBS
Boehringer Ingelheim
Medtronic
Cantor Fitzgerald
QuintilesIMS
McKesson
AstraZeneca

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008453

« Back to Dashboard
NDA 008453 describes ANECTINE, which is a drug marketed by Sandoz Inc and is included in one NDA. It is available from one supplier. Additional details are available on the ANECTINE profile page.

The generic ingredient in ANECTINE is succinylcholine chloride. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.

Summary for NDA: 008453

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 008453

Suppliers and Packaging for NDA: 008453

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANECTINE
succinylcholine chloride
INJECTABLE;INJECTION 008453 NDA Sandoz Inc 0781-3009 0781-3009-95 10 VIAL, MULTI-DOSE in 1 CARTON (0781-3009-95) > 10 mL in 1 VIAL, MULTI-DOSE (0781-3009-70)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Merck
Citi
Novartis
Mallinckrodt
Fish and Richardson
Dow
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot